StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Pfizer (PFE) PT Raised to $54 at Barclays
December 10, 2021 4:36 AM
Barclays analyst Carter Gould raised ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst PT Change
Next Articles
Low Valuations to Drive Pharma M&A in 2022 - Analyst
December 13, 2021 8:50 AM
Pfizer (PFE) to Buy Arena Pharmaceuticals (ARNA) in a $6.7 Billion Deal, Pays a 100% Premium; Seen as the First of Many Acquisitions
December 13, 2021 6:41 AM
Pfizer (PFE) Raises Quarterly Dividend 2.6% to $0.40; 3% Yield
December 10, 2021 12:01 PM
Pfizer's (PFE) Cibinqo Approved in EU for Treatment of Adults with Moderate-to-Severe Atopic Dermatitis
December 10, 2021 9:27 AM
